Content about pharmaceutical

COVINGTON, Ky. A company that provides pharmaceutical care for the elderly is splitting its pharmacy services business into two divisions, hoping to make its services more effective and focused on customers.

VALLEY FORGE, Pa. Earnings per share for AmerisourceBergen rose nearly 14% during the fourth quarter ended Sept. 30, thanks to key growth in two sectors, the pharmaceutical services company said.

Diluted earnings per share were 50 cents for the quarter, a 13.6% increase compared with the year-ago period. Revenue also increased to a record $19.7 billion, a 5.3% gain for the company.

ORLANDO, Fla. Intelligent Global Pooling Systems has developed a pallet rental service providing 100% recyclable all-plastic pallets with embedded radio frequency identification tags.

iGPS bios will offer premier hygiene and secure pallets, ideal for those in the pharmaceutical and life science industries, as well as savings for a company's bottom line, iGPS said. Each pallet is individually washed and sanitized at an iGPS facility, then immediately enclosed in protective wrapping to maintain its hygienic condition, the company added.

WHAT IT MEANS AND WHY IT'S IMPORTANT Scale matters.

(THE NEWS: Walgreens names SVP pharmaceutical development, market access. For the full story, click here)

DEERFIELD, Ill. Walgreens announced Thursday that Jeffrey Berkowitz, a former SVP at drug maker Merck, has joined the company.

Berkowitz will serve as Walgreens' SVP pharmaceutical development and market access, responsible for the overall pharmacy contracting strategy for the company, both on the pharmaceutical manufacturing side and on the retail payer side, the drug store chain said. He will report to Walgreens' pharmacy services president Kermit Crawford.

WASHINGTON —The pharmaceutical industry earlier this month weighed in on the case “Matrixx Initiatives vs. James Siracusano and NECA-IBEW Pension Fund.”

BOSTON Close to 400 drugs and vaccines are in development for fighting infectious diseases, according to one of the pharmaceutical industry’s largest lobbying groups.

The Pharmaceutical Research and Manufacturers of America announced Friday that drug makers have 395 new medicines and vaccines in clinical development or under review by the Food and Drug Administration. These include five vaccines and six drugs for malaria, as well as agents for infections like cholera, methicillin-resistant Staphylococcus aureus and the Ebola virus.